---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-091055"
form_type: "8-K"
ticker: "ACHV"
cik: "0000949858"
company_name: "ACHIEVE LIFE SCIENCES, INC."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T17:17:13.158074+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Achieve Life Sciences prices $45M offering: 15M shares and warrants at $3.00 per unit

## Summary
- Public offering of 15M shares of common stock and accompanying warrants to purchase up to 15M shares, priced at $3.00 per unit.
- Gross proceeds ~$45M; net proceeds ~$41.3M after underwriting discounts and expenses; expected close June 30, 2025.
- Underwriters granted 30-day option to purchase up to an additional 2.25M shares and/or warrants.
- Each warrant exercisable for one share at $3.00, or exchangeable for pre-funded warrant at $0.001/share; 5-year term; 9.99% ownership cap.
- Proceeds to fund cytisinicline advancement for smoking cessation through potential FDA approval and for working capital.

## SEC filing metadata
- accession: 0000950170-25-091055
- form_type: 8-K
- ticker: ACHV
- cik: 0000949858
- company_name: ACHIEVE LIFE SCIENCES, INC.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/949858/000095017025091055/0000950170-25-091055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/949858/000095017025091055/achv-20250626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-091055
- JSON: https://secwatch.observer/filing/0000950170-25-091055.json
- Plain text: https://secwatch.observer/filing/0000950170-25-091055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.